🧬 3 terapias innovadoras
🇨🇳 Aprobadas en China
🎯 Para melanoma avanzado

📎 Más información: dengyuepharma.com
📧 info@dengyuemed.com
#Toripalimab #Tunlametinib #Pucotenlimab #Melanoma #TratamientoOncológico #Inmunoterapia #DengYueMedicinasEnHongKong

Combining the mTORC1/2 inhibitor #onatasertib with the #PD1antibody #toripalimab offers a manageable safety profile and promising efficacy in advanced #SolidTumors—especially recurrent or #MetastaticCervicalCancer—regardless of #PDL1 expression.

#STTT: doi.org/10.1038/s413...

Groundbreaking Study on Disitamab Vedotin as First-Line Therapy for Urothelial Carcinoma Unveiled at ESMO 2025 A pivotal study presented at the ESMO 2025 Congress reveals disitamab vedotin combined with toripalimab significantly outperforms standard chemotherapy for urothelial carcinoma patients.

Groundbreaking Study on Disitamab Vedotin as First-Line Therapy for Urothelial Carcinoma Unveiled at ESMO 2025 #None #Berlin #Disitamab_Vedotin #Urothelial_Carcinoma #Toripalimab

A multicenter, nonrandomized phase 1/2 trial on #onatasertib in combination with #toripalimab in patients with advanced solid tumors demonstrated a manageable safety profile and encouraging antitumor activity. #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...

Mabwell to Unveil Clinical Findings of 9MW2821 and Toripalimab for Urothelial Carcinoma at ASCO 2025 Mabwell will present groundbreaking clinical data for 9MW2821 combined with toripalimab in urothelial carcinoma patients at ASCO 2025, showcasing innovation in biopharmaceuticals.

Mabwell to Unveil Clinical Findings of 9MW2821 and Toripalimab for Urothelial Carcinoma at ASCO 2025 #USA #Chicago #Mabwell #Toripalimab #9MW2821

Toripalimab (Loqtorzi): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Discover how Toripalimab (Loqtorzi) treats cancer, its side effects, dosage info, and what patients can expect from this innovative immunotherapy.

Toripalimab (Loqtorzi): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/toripa...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Toripalimab #Loqtorzi #FDA

Breakthrough Phase II Clinical Trial Results for Bladder Cancer Treatment at ASCO GU 2025 Recent data from a Phase II trial showcases the effectiveness of Disitamab Vedotin and Toripalimab for treating bladder cancer, offering hope for patients.

Breakthrough Phase II Clinical Trial Results for Bladder Cancer Treatment at ASCO GU 2025 #USA #San_Francisco #RemeGen #Disitamab_Vedotin #Toripalimab

Dr. Reddy's launches Toripalimab in India to treat rare form of head & neck cancer - Yes Punjab News Dr. Reddy's Laboratories launches Toripalimab in India for the treatment of Nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer. The PD-1 inhibitor has shown promising results in reduc...

Dr. Reddy's launches Toripalimab in India to treat rare form of head & neck cancer
yespunjab.com?p=66485

#DrReddys #Toripalimab #NasopharyngealCarcinoma #NPC #HeadCancer #NeckCancer #CancerTreatment #Immunotherapy